Entheon Biomedical: Funding, Investors & Team (Sep 2026)
Entheon is a biotechnology research and development company committed to developing and commercializing a portfolio of safe and effective Dimethyltryptamine based psychedelic therapeutic products ("DMT Products") for the purposes of treating addiction and substance use disorders. Subject to obtaining all requisite regulatory approvals and permits, Entheon intends to generate revenue through the sale of its DMT Products to physicians, clinics and licensed psychiatrists in the United States, certain countries in the European Union and throughout Canada.
Entheon Biomedical has raised $3.0M across 1 funding round on record, the most recent a Post-IPO Equity of $3.0M announced in Apr 2022.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Entheon Biomedical Company Profile and Key Stats
Latest funding round on record: Apr 2022.
Entheon Biomedical Funding Rounds
Entheon Biomedical Founders and Leadership Team
Contact details for the Entheon Biomedical team: 1 of 1 has an email address on file.
Start 14-day free trial →Entheon Biomedical Funding Compared to Other Biotechnology Startups
Entheon Biomedical's latest round of $3.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Entheon Biomedical in Biotechnology and Coquitlam
Companies Similar to Entheon Biomedical
Medicenna is a clinical-stage immunotherapy company focused on oncology and the development and…
Cybin is a clinical-stage biopharmaceutical company on a mission to create safe and effective…
Hemostemix Inc. is a Canadian biotechnology company that specializes in creating blood-derived cell therapies…
Avicanna is an organization in the biopharmaceutical sector that concentrates on enhancing medical cannabis…
Edesa Biotech is a privately-held company in the clinical stage that specializes in creating therapies for…
ME Therapeutics is a biotech company that specializes in finding and creating drugs for immuno-oncology that…
Aurinia Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing and…
Medicus Pharma is a biotechnology research company that fast-tracks the progress of life sciences and…
ProteinQure is a biotechnology company specializing in creating innovative peptides for various medical…
Anodyne's mission is to create critical chemicals sustainably. Anodyne's approach takes advantage of nature's…
NervGen Pharma is a medicine company dedicated to creating solutions for the treatment of nerve damage and…
ZYUS is a biopharmaceutical company focused on providing patients with cannabinoids and other plant-based…
Entheon Biomedical Funding FAQs
What does Entheon Biomedical do?
Entheon is a biotechnology research and development company committed to developing and commercializing a portfolio of safe and effective Dimethyltryptamine based psychedelic therapeutic products ("DMT Products") for the purposes of treating addiction and substance use disorders. Subject to obtaining all requisite regulatory approvals and permits, Entheon intends to generate revenue through the sale of its DMT Products to physicians, clinics and licensed psychiatrists in the United States, certain countries in the European Union and throughout Canada.
How much funding has Entheon Biomedical raised?
Entheon Biomedical has raised $3.0M across 1 round on record. The most recent is a Post-IPO Equity of $3.0M announced in Apr 2022.
When did Entheon Biomedical last raise funding?
Entheon Biomedical's most recent funding round on record is a Post-IPO Equity of $3.0M, announced in Apr 2022.
Who is the CEO of Entheon Biomedical?
Timothy Ko is listed as CEO at Entheon Biomedical.
Where is Entheon Biomedical headquartered?
Entheon Biomedical is based in Coquitlam, British Columbia, Canada.
How many employees does Entheon Biomedical have?
Entheon Biomedical is in the 11-50 employee band.
How does Entheon Biomedical's funding compare to other Biotechnology startups?
Entheon Biomedical's latest round of $3.0M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Entheon Biomedical Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Entheon Biomedical is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.